Willowcroft Pharm Inc — Form D

Willowcroft Pharm Inc of DENVER, CO, a company, filed a Form D exempt-offering notice with the SEC on 2014-04-25. The offering totals $5.0M. Industry: Pharmaceuticals.

Offering

• Filed: 2014-04-25
• Form: D
• Accession: 0001605460-14-000002
• Industry: Pharmaceuticals
• Exemptions: 06c
• Total offering: $5.0M
• Remaining: $5.0M
• Minimum investment: $50K
• Security types: equity
• Revenue range: $1 - $1,000,000
• SEC file number: 021-216281

Issuer

• Name: Willowcroft Pharm Inc
• CIK: 0001605460
• Entity type: Corporation
• Jurisdiction: COLORADO
• Incorporated: 2009
• Address: 820 GRAPE STREET, DENVER, CO, 80220
• Phone: 303-875-7402

Officers, directors & promoters (1)

More

• CIK 1605460 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search